losartan has been researched along with Urinary Incontinence, Stress in 2 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Urinary Incontinence, Stress: Involuntary discharge of URINE as a result of physical activities that increase abdominal pressure on the URINARY BLADDER without detrusor contraction or overdistended bladder. The subtypes are classified by the degree of leakage, descent and opening of the bladder neck and URETHRA without bladder contraction, and sphincter deficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pharmacological treatment for stress urinary incontinence (SUI) is limited to the use of non-selective alpha-agonists, which are often ineffective." | 1.34 | The role of angiotensin II in stress urinary incontinence: A rat model. ( Comiter, CV; Escobar, C; Phull, H; Purves, T; Salkini, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Phull, H | 1 |
| Salkini, M | 1 |
| Escobar, C | 1 |
| Purves, T | 1 |
| Comiter, CV | 1 |
| Lee, YJ | 1 |
| Chiang, YF | 1 |
| Tsai, JC | 1 |
1 trial available for losartan and Urinary Incontinence, Stress
| Article | Year |
|---|---|
Severe nonproductive cough and cough-induced stress urinary incontinence in diabetic postmenopausal women treated with ACE inhibitor.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cough; Diabetic Angiopathies; Double-Blind Method; Female; | 2000 |
1 other study available for losartan and Urinary Incontinence, Stress
| Article | Year |
|---|---|
The role of angiotensin II in stress urinary incontinence: A rat model.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; An | 2007 |